ArticlePloS one2013

Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.

Melchiorre Cervello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.